Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
15.50
+0.40 (2.65%)
At close: Mar 9, 2026, 4:00 PM EDT
15.68
+0.18 (1.19%)
After-hours: Mar 9, 2026, 5:14 PM EDT
Nurix Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is December - November.
Millions USD. Fiscal year is Dec - Nov.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Nov '25 Nov 30, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 |
| Market Capitalization | 1,594 | 1,792 | 1,566 | 302 | 584 | 1,286 | |
| Market Cap Growth | 23.27% | 14.43% | 419.13% | -48.35% | -54.57% | -22.36% | |
| Enterprise Value | 989 | 1,420 | 1,136 | 41 | 184 | 942 | |
| Last Close Price | 15.10 | 17.68 | 22.11 | 6.22 | 12.39 | 28.82 | |
| PS Ratio | 18.17 | 21.34 | 28.71 | 3.92 | 15.12 | 43.22 | |
| PB Ratio | 2.85 | 3.33 | 2.97 | 1.51 | 1.92 | 3.76 | |
| P/TBV Ratio | 2.83 | 3.33 | 2.97 | 1.51 | 1.92 | 3.76 | |
| EV/Sales Ratio | 11.78 | 16.91 | 20.82 | 0.53 | 4.76 | 31.66 | |
| Debt / Equity Ratio | 0.10 | 0.10 | 0.05 | 0.15 | 0.04 | 0.04 | |
| Net Debt / Equity Ratio | -1.00 | -1.00 | -1.10 | -1.32 | -1.19 | -1.23 | |
| Net Debt / EBITDA Ratio | 1.94 | 1.94 | 2.84 | 1.78 | 2.01 | 3.62 | |
| Net Debt / FCF Ratio | 2.04 | 2.04 | 3.20 | 2.95 | 2.10 | 4.66 | |
| Asset Turnover | 0.12 | 0.12 | 0.11 | 0.20 | 0.09 | 0.07 | |
| Quick Ratio | 6.87 | 6.87 | 6.38 | 3.32 | 4.39 | 4.57 | |
| Current Ratio | 7.02 | 7.02 | 6.46 | 3.40 | 4.51 | 4.70 | |
| Return on Equity (ROE) | -49.63% | -49.63% | -53.22% | -57.10% | -55.84% | -37.05% | |
| Return on Assets (ROA) | -26.30% | -26.30% | -25.98% | -25.10% | -25.72% | -16.88% | |
| Return on Capital Employed (ROCE) | -47.50% | -47.50% | -37.10% | -57.70% | -53.10% | -28.70% | |
| Earnings Yield | -17.33% | -14.76% | -12.36% | -47.71% | -30.88% | -9.12% | |
| FCF Yield | -17.26% | -14.70% | -11.61% | -29.75% | -29.45% | -7.00% | |
| Buyback Yield / Dilution | -29.12% | -29.12% | -23.52% | -11.79% | -13.32% | -173.68% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.